Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of CFTR modulators in special populations, part 1: Pregnancy and lactation.

Pediatric pulmonology - 1 Dec 2023

Elijah Joseph, Fitzgerald Linda J, Phan Hanna

Abstract excerpt

Safety and efficacy data regarding cystic fibrosis transmembrane conductance regulator (CFTR) modulator use in the setting of pregnancy or breastfeeding remains lacking due to exclusion from key trials and lack of multicenter prospective and retrospective studies in the post-CFTR modulator era. A scoping review of English articles from the period of January 1, 2012, to July 31, 2023, was conducted utilizing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Benzodioxoles
Share to Breast Feeding

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Lactation

Share to Mutation

Share to Pregnancy

Source

Identifiers

PMID: 37787417
DOI: 10.1002/ppul.26706

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of CFTR modulators in special populations, part 1: Pregnancy and lactation.PMID 37787417Read ↗

"Shifting sands in cystic fibrosis": impacts of CFTR modulators on reproductive health in people with cystic fibrosis and challenges related to in utero exposure.Semantic proximity Read ↗

Use of CFTR modulators in special populations, part 2: Severe lung disease.Semantic proximity Read ↗

CFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic FibrosisSemantic proximity Read ↗

Review of CFTR modulators 2020.Semantic proximity Read ↗

Pregnancy in cystic fibrosis: Review of the literature and expert recommendationsSemantic proximity Read ↗

The New and Advanced Cystic fibrosis transmembrane conductance regulators Modulators in Children with Cystic Fibrosis: A Narrative Review on Long-Term Outcomes, Recent Advances, and Comparative Insights.Semantic proximity Read ↗

CFTR pharmacological modulators: A great advance in cystic fibrosis management.Semantic proximity Read ↗

First real-world study of fetal therapy with CFTR modulators in cystic fibrosis: Report from the MODUL-CF studySemantic proximity Read ↗

Pregnancy in Cystic Fibrosis: Review of the Literature and Expert RecommendationsSemantic proximity Read ↗

Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis.Semantic proximity Read ↗

CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in FranceSemantic proximity Read ↗

To be or not to be on CFTR modulators during pregnancy: Risks to be considered.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.